Population-based study of high plasma C-reactive protein concentrations among the Inuit of Nunavik

International Journal of Circumpolar Health

Volumn 71, Issue 1, 2012, Pages

  Labonté, Marie Eve ^a   Dewailly, Eric ^b   Chateau Degat, Marie Ludivine ^b   Couture, Patrick ^a,b   Lamarche, Benoît ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Aging; C reactive protein; Inuit; Nunavik; Prevalence; Risk factors; Sex; Systolic blood pressure; Waist circumference

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CANADA; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ESKIMO; ETHNOLOGY; FEMALE; GENETICS; HUMAN; HYPERTENSION; LIFESTYLE; MALE; MIDDLE AGED; NUNAVIK; OBESITY; PREVALENCE; RISK FACTOR; SEX; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; WAIST CIRCUMFERENCE;

AGING; C-REACTIVE PROTEIN; INUIT; NUNAVIK; PREVALENCE; RISK FACTORS; SEX; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; INUITS; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; QUEBEC; RISK FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84872912931     PISSN: 12399736     EISSN: 22423982     Source Type: Journal    
DOI: 10.3402/ijch.v71i0.19066     Document Type: Article

References (37)

1. Sharma S. Assessing diet and lifestyle in the Canadian Arctic Inuit and Inuvialuit to inform a nutrition and physical activity intervention programme. J Hum Nutr Diet. 2010;23(Suppl 1):5-17.
2. Dewailly E, Chateau-Degat ML, Ekoé JM, Ladouceur R, Rochette L. Status of cardiovascular disease and diabetes in Nunavik. Nunavik Inuit Health Survey 2004, Qanuippitaa? How are we?. Québec, Canada: Gouvernement du Québec - Institut national de santé publique du Québec (INSPQ) & Nunavik Regional Board of Health and Social Services (NRBHSS); 2007.
3. Chateau-Degat ML, Dewailly E, Charbonneau G, Laouan-Sidi EA, Tremblay A, Egeland GM. Obesity risks: towards an emerging Inuit pattern. Int J Circumpolar Health. 2011;70: 166-77.
4. Ayach BB, Korda H. Commentary: type 2 diabetes epidemic in first nations people of Canada. Ethn Dis. 2010;20:300-3.
5. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men - results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg cohort study, 1984 to 1992. Circulation. 1999;99:237-42.
6. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342:836-43.
7. Howard BV, Comuzzie A, Devereux RB, Ebbesson SOE, Fabsitz RR, Howard WJ, et al. Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos. Nutr Metab Cardiovasc Dis. 2010;20:350-8.
8. Cutchins A, Roman MJ, Devereux RB, Ebbesson SOE, Umans JG, Zhu J, et al. Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos the GOCADAN study. Stroke. 2008;39:3079-82.
9. Rochette L, Blanchet C. Methodological Report. Nunavik Inuit Health Survey 2004, Qanuippitaa? How are we?. Québec, Canada: Gouvernement du Québec - Institut national de santé publique du Québec (INSPQ) & Nunavik Regional Board of Health and Social Services (NRBHSS); 2007.
10. Chateau-Degat ML, Dewailly E, Louchini R, Counil E, Noël M, Ferland A, et al. Cardiovascular burden and related risk factors among Nunavik (Quebec) Inuit: insights from baseline findings in the circumpolar Inuit health in transition cohort study. Can J Cardiol. 2010;26:190-6.
11. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366:1059-62.
12. Chockalingham A. Canadian coalition for high blood pressure prevention and control: referral and treatment guidelines. St. John, NL, Canada: Faculty of Medicine, Memorial University of Newfoundland; 1988.
13. Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Despres JP, et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med. 2001;161:2474-80.
14. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/ Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol. 2009;25:567-79.
15. Charbonneau-Roberts G, Saudny-Unterberger H, Kuhnlein HV, Egeland GM. Body mass index may overestimate the prevalence of overweight and obesity among the Inuit. Int J Circumpolar Health. 2005;64:163-9.
16. SAS Institute Inc. SAS/STAT® Software: changes and enhancements, Release 8.2. Chapter 9: the MI procedure. Cary, NC: SAS Institute Inc; 2001. p. 131-6.
17. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-9.
18. Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B. Relation of waist circumference and glycemic status to Creactive protein in the Sandy Lake Oji-Cree. Int J Obes. 2003;27:347-54.
19. Anand SS, Razak F, Yi QL, Davis B, Jacobs R, Vuksan V, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol. 2004;24:1509-15.
20. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in Creactive protein levels. J Am Coll Cardiol. 2005;46:464-9.
21. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol. 2001;8:131-6.
22. Hegele RA, Ban MR, Young TK. Serum C-reactive protein in Canadian Inuit and its association with genetic variation on chromosome 1q21. Clin Chem. 2001;47:1707-9.
23. Neyestani TR, Salekzamani S, Kalayi A, Alavi-Majd H, Houshiarrad A, Nikooyeh B, et al. Predictors of serum levels of high sensitivity C-reactive protein and systolic blood pressure in overweight and obese nondiabetic women in Tehran: a cross-sectional study. Metab Syndr Relat Disord. 2011;9:41-7.
24. Gentile M, Panico S, Rubba F, Mattiello A, Chiodini P, Jossa F, et al. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women. Eur J Clin Nutr. 2010;64:873-8.
25. Villegas R, Xiang YB, Cai H, Elasy T, Cai Q, Zhang X, et al. Lifestyle determinants of c-reactive protein in middle-aged, urban Chinese men. Nutr Metab Cardiovasc Dis. 2012;22: 223-30.
26. Hung J, Knuiman MW, Divitini ML, Davis T, Beilby JP. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol. 2008;101:193-8.
27. Simões E Silva AC, Flynn JT. The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease. Pediatr Nephrol. 2012;27:1835-45.
28. Savoia C, Burger D, Nishigaki N, Montezano A, Touyz RM. Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med. 2011;13:e11.
29. Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev. 2012;13:136-49.
30. Han Y, Runge MS, Brasier AR. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res. 1999;84:695-703.
31. Kranzhofer R, Schmidt J, Pfeiffer CAH, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1623-9.
32. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, et al. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol. 2009;296:R208-16.
33. Yvan-Charvet L, Massiera F, Lamande N, Ailhaud G, Teboul M, Moustaid-Moussa N, et al. Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue. Endocrinology. 2009;150:1421-8.
34. Ruiz-Ortega M, Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Carvajal G, et al. Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens. 2006;15:159-66.
35. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-Reactive protein gene-expression by interleukin- 1 and interleukin-6. EMBO J. 1989;8:3773-9.
36. Ebrahimi A, Nabipour I, Vahdat K, Jafari SM, Fouladvand M, Assadi M, et al. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden. Diabetes Res Clin Pract. 2009;84:296-302.
37. Ishii S, Karlamangla AS, Bote M, Irwin MR, Jacobs DRJ, Cho HJ, et al. Gender, obesity and repeated elevation of Creactive protein: data from the CARDIA cohort. PLoS One. 2012;7:e36062.